Smart + Strong.
All Rights Reserved.
Smart + Strong®
is a registered trademark of CDM Publishing, LLC.
Surprise: GOP health chief backs needle exchanges as prevention. But the health secretary does not support safe injection sites.
Highlights from HIV and hepatitis C research presented at the 2018 Conference on Retroviruses and Opportunistic Infections (CROI) in Boston
The city wants to reduce its number of opioid-related deaths.
But advocates say they are needed to address the city’s heroin and opioid crisis.
The CDC currently recommends that HBV-positive patients be treated in a private room, away from other patients.
The hepatitis C pipeline: huge changes on the horizon
Getting rid of acute hepatitis C virus (HCV) infection once, whether it is cleared by strong immune response during the initial months of infe...
Although hepatitis C virus (HCV) is a common and serious coinfection among people living with HIV, it often goes undiagnosed, even in a major...
Prolonged therapy with antiretroviral regimens containing tenofovir is associated with a decline in hepatitis B surface antigen (HBsAg) levels...
Most research on mother-to-child transmission (MTCT) of hepatitis C was done before there was widespread access to combination ARV therapy
Rates of antiretroviral (ARV)-associated liver toxicity among people living with HIV and hepatitis C virus (HCV) have decreased since 1997, bu...
Despite rapid reductions in hepatitis C virus (HCV) levels in 10 previously treated null responders with genotype 1 HCV, only one person had a...
Adding a protease inhibitor to pegylated interferon and ribavirin as part of hepatitis C virus (HCV) treatment resulted in higher sustained vi...
You have been inactive for 60 minutes and will be logged out in . Any updates not saved will be lost.
Click here to log back in.